In addition, high IL13Rα2 expression could specifically predict metastasis-free survival of patients with high- but not low-grade tumors (Fig. 1b), suggesting that overexpression of this gene may be involved in promoting the late stages of tumor progression. The gene discussed is IL13RA2; the disease is neoplasm.